Cell-Free DNA as a Biomarker at Diagnosis and Follow-Up in 256 B and T-Cell Lymphomas.
Ramón Diez-FeijóoMarcio Andrade-CamposJoan GibertBlanca Sánchez-GonzálezLierni Fernández-IbarrondoMaria Concepción Fernández-RodríguezNieves Garcia-GisbertLaura CamachoMarta LafuenteIvonne VázquezLluís ColomoAntonio Salar-SilvestreBeatriz BellosilloPublished in: Cancers (2024)
cfDNA analysis can be easily performed in almost all lymphoma cases. The cfDNA concentration correlated with the characteristics of the aggressiveness of the lymphomas and, in LBCL, with the response achieved after therapy. These results support the utility of cfDNA analysis as a complementary tool in the management of lymphoma patients.